Bajaj Consumer Care Results Update

Bajaj Consumer Care Annual General Meeting

Bajaj Consumer Care issued a postal ballot notice to appoint Mr. Jitendra Mahajan as Independent Director. Voting window closes 28 November 2026.

Bajaj Consumer Care Management Change

Bajaj Consumer Care intimated a postal ballot notice seeking shareholder approval to appoint Mr. Jitendra Mahajan as Non-Executive Independent Director for five years. E-voting runs 30 Oct to 28 Nov 2026.

Execution

Director term 14 Oct 2026 to 13 Oct 2031

Bajaj Consumer Care Earnings Call Transcript: Key Takeaways

Q2 FY27 revenue grew 2.7% YoY to ₹233 Cr. Management maintained 25% EBITDA and 21% PAT margins despite raw material volatility, focusing on distribution expansion via Project Aarohan 2.0.

Call

Guides 18% growth

Bajaj Consumer Care Management Change

Bajaj Consumer Care Limited announced the resignation of Independent Director Mr. K. S. Narayanan, effective October 14, 2026, citing personal medical reasons and professional commitments.

Bajaj Consumer Care Investor Presentation: Key Takeaways

Bajaj Consumer Care reported strong Q2 FY27 performance with consolidated revenue at ₹332.7 Cr, up 27.3% YoY. EBITDA margins expanded to 25% from 18.6% YoY.

Bajaj Consumer Care Q2 FY27 Results: Net Profit ₹70.2 Cr, Up 66.0% YoY

Bajaj Consumer Care Ltd reported revenue from operations of ₹332.8 Cr (+25.4% YoY) and net profit of ₹70.2 Cr (+66.0% YoY) for Q2 FY27.

Key figure

Net profit ₹70.2 Cr · +66.0% YoY

Medi Assist Healthcare Services Results Update

Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.

Neogen Chemicals Results Update

Neogen Chemicals issued its Q2 FY27 press release on unaudited results, showing higher year-on-year revenue and profit. Battery chemicals ramp-up and the QIP proceeds featured prominently.

Surani Steel Tubes Results Update

Surani Steel Tubes issued an earnings press release for H1 FY27, reporting revenue of Rs.290.86 Crore and PAT of Rs.5.94 Crore. The release states that both figures exceed the company's previous full-year records.

Shree Ganesh Remedies Results Update

Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.

Zen Technologies Results Update

Zen Technologies released its Q2 and H1 FY27 unaudited results, reporting consolidated Q2 revenue of ₹345.13 Crore, up 98.8% year-on-year. Order book stands at ₹1,375.70 Crore.

Order book

₹1,376 Cr

Sai Parenterals Results Update

Sai Parenterals reported Q2FY27 consolidated revenue of Rs. 196 crore and PAT of Rs. 11 crore. Gross margin improved to 47.5%.